REGN vs WAB · P/E 14, rev $14.34B vs P/E 38, rev $11.17B
Regeneron Pharmaceuticals Inc (REGN) versus Westinghouse Air Brake Technologies Corp (WAB) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Westinghouse Air Brake Technologies Corp (WAB) is a railroads company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported WAB revenue for 2025-12-31 was $11.17B. Net income was $1.17B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
Not investment advice. Open the REGN and WAB stock pages for the full models.
Not investment advice.